86 related articles for article (PubMed ID: 9046342)
1. Cytotoxicity of platinum (II) dinuclear complexes with 1-alkylthymine ligands against mouse sarcoma 180 cells.
Rekonen P; Dohta Y; Kodaka M; Okada T; Okamoto K; Okuno H
J Med Chem; 1997 Feb; 40(4):515-9. PubMed ID: 9046342
[TBL] [Abstract][Full Text] [Related]
2. Palladium(II) and platinum(II) organometallic complexes with the model nucleobase anions of thymine, uracil, and cytosine: antitumor activity and interactions with DNA of the platinum compounds.
Ruiz J; Lorenzo J; Sanglas L; Cutillas N; Vicente C; Villa MD; Avilés FX; López G; Moreno V; Pérez J; Bautista D
Inorg Chem; 2006 Aug; 45(16):6347-60. PubMed ID: 16878945
[TBL] [Abstract][Full Text] [Related]
3. Chemistry, antiproliferative activity and low nephrotoxicity of 3,5-diacetyl-1,2,4-triazol bis(4N-thiosemicarbazone) ligands and their platinum(II) complexes.
Matesanz AI; Joie C; Souza P
Dalton Trans; 2010 Aug; 39(30):7059-65. PubMed ID: 20571622
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, structures and in vitro cytotoxicity of some platinum(II) complexes containing thiocarbamate esters.
Dolfen D; Schottler K; Valiahdi SM; Jakupec MA; Keppler BK; Tiekink ER; Mohr F
J Inorg Biochem; 2008 Dec; 102(12):2067-71. PubMed ID: 18707761
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and anticancer activity of [2-hydroxy-1,3-diaminopropane-kappa 2N,N'] platinum(II) complexes.
Liu W; Chen X; Xie M; Lou L; Ye Q; Yu Y; Hou S
J Inorg Biochem; 2008 Oct; 102(10):1942-6. PubMed ID: 18707762
[TBL] [Abstract][Full Text] [Related]
6. Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O.
Ali MS; Khan SR; Ojima H; Guzman IY; Whitmire KH; Siddik ZH; Khokhar AR
J Inorg Biochem; 2005 Mar; 99(3):795-804. PubMed ID: 15708801
[TBL] [Abstract][Full Text] [Related]
7. Antitumor effect of Pt(II) amine phosphonate complexes on sarcoma sa-180 in mice. Crystal structure of cis-dichlorobis(diethyl-4-pyridylmethylphosphonate-kappaN)platinum(II) hydrate, cis-[PtCl2(4-pmpe)2].H20.
Aranowska K; Graczyk J; Checińska L; Pakulska W; Ochock J
Pharmazie; 2006 May; 61(5):457-60. PubMed ID: 16724546
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterization and cytotoxicity of ammine/ethylamine platinum(II) complexes with carboxylates.
Zhang J; Li Y; Sun J
Eur J Med Chem; 2009 Jun; 44(6):2758-62. PubMed ID: 19056150
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and cytotoxicity of platinum(II) complexes of a physiologically active carrier histamine.
Chen XZ; Ye QS; Lou LG; Xie MJ; Liu WP; Yu Y; Hou SQ
Arch Pharm (Weinheim); 2008 Feb; 341(2):132-6. PubMed ID: 18186542
[TBL] [Abstract][Full Text] [Related]
10. New isomeric azine-bridged dinuclear platinum(II) complexes circumvent cross-resistance to cisplatin.
Komeda S; Kalayda GV; Lutz M; Spek AL; Yamanaka Y; Sato T; Chikuma M; Reedijk J
J Med Chem; 2003 Mar; 46(7):1210-9. PubMed ID: 12646031
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, characterization, interaction with DNA and cytotoxicity in vitro of dinuclear Pd(II) and Pt(II) complexes dibridged by 2,2'-azanediyldibenzoic acid.
Gao E; Zhu M; Yin H; Liu L; Wu Q; Sun Y
J Inorg Biochem; 2008 Oct; 102(10):1958-64. PubMed ID: 18760841
[TBL] [Abstract][Full Text] [Related]
12. Palladium(II) and platinum(II) organometallic complexes with 4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine. Antitumor activity of the platinum compounds.
Ruiz J; Villa MD; Cutillas N; López G; de Haro C; Bautista D; Moreno V; Valencia L
Inorg Chem; 2008 Jun; 47(11):4490-505. PubMed ID: 18447329
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, cytotoxicity and DNA-binding levels of ammine/propylamine platinum(II) complexes with carboxylates.
Zhang J; Zhao X
Eur J Med Chem; 2007 Feb; 42(2):286-91. PubMed ID: 17084487
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo antitumor activity of platinum(II) complexes with thiosemicarbazones derived from 2-formyl and 2-acetyl pyridine and containing ring incorporated at N(4)-position: synthesis, spectroscopic study and crystal structure of platinum(II) complexes with thiosemicarbazones, potential anticancer agents.
Kovala-Demertzi D; Papageorgiou A; Papathanasis L; Alexandratos A; Dalezis P; Miller JR; Demertzis MA
Eur J Med Chem; 2009 Mar; 44(3):1296-302. PubMed ID: 18848372
[TBL] [Abstract][Full Text] [Related]
15. Crystal structures and cytotoxicity of isopropylamine Pt(II) complexes: a trinuclear squarato-bridged [Pt3(mu2-C4O4)3(H2NPri)6].3H2O and a mononuclear cis-[Pt(NO3)2(H2NPri)2].
Grabner S; Modec B; Cemazar M; Bukovec N
J Inorg Biochem; 2005 Jul; 99(7):1465-71. PubMed ID: 15927264
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, structural characterization, and biological studies of new antimony(III) complexes with thiones. The influence of the solvent on the geometry of the complexes.
Ozturk II; Hadjikakou SK; Hadjiliadis N; Kourkoumelis N; Kubicki M; Baril M; Butler IS; Balzarini J
Inorg Chem; 2007 Oct; 46(21):8652-61. PubMed ID: 17850141
[TBL] [Abstract][Full Text] [Related]
17. Platinum(II) complexes with l-methionylglycine and l-methionyl-l-leucine ligands: synthesis, characterization and in vitro antitumoral activity.
Kaluderović GN; Schmidt H; Paschke R; Kalinowski B; Dietrich A; Mueller T; Steinborn D
J Inorg Biochem; 2007 Mar; 101(3):543-9. PubMed ID: 17223197
[TBL] [Abstract][Full Text] [Related]
18. New palladium(II) and platinum(II) complexes with the model nucleobase 1-methylcytosine: antitumor activity and interactions with DNA.
Ruiz J; Cutillas N; Vicente C; Villa MD; López G; Lorenzo J; Avilés FX; Moreno V; Bautista D
Inorg Chem; 2005 Oct; 44(21):7365-76. PubMed ID: 16212362
[TBL] [Abstract][Full Text] [Related]
19. Platinum (II) complexes with stereochemically-defined thiepane dioxide diamine ligands as anticancer drugs.
Cerè V; Grossi L; Munari D; Pollicino S; Martelli L; Martelli M
Anticancer Res; 2006; 26(3A):1815-9. PubMed ID: 16827112
[TBL] [Abstract][Full Text] [Related]
20. Mononuclear platinum(II) complex with 2-phenylpyridine ligands showing high cytotoxicity against mouse sarcoma 180 cells acquiring high cisplatin resistance.
Okada T; El-Mehasseb IM; Kodaka M; Tomohiro T; Okamoto K; Okuno H
J Med Chem; 2001 Dec; 44(26):4661-7. PubMed ID: 11741483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
